Luigi Moro
Chief Tech/Sci/R&D Officer at CASSIOPEA S.P.A.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Pierpaolo Guzzo | M | 56 | 9 years | |
Marco Lecchi | M | 60 | 23 years | |
Marco Pasero | M | 58 | 9 years | |
Dieter A. Enkelmann | M | 64 | 18 years | |
Maria Grazia Roncarolo | M | 69 | 12 years | |
Alessandro Mazzetti | M | 72 | 7 years | |
Kevin Joseph Donovan | M | 65 | 8 years | |
Niall Donnelly | M | 52 | 8 years | |
Alessandro Della Chà | M | 61 | 18 years | |
Antonio Carnevali | M | - | - | |
Roberto Lazzarone | M | - | - | |
Davide Malavasi | M | 51 | 13 years | |
Dave Wood | M | - | 5 years | |
Luigi Longo | M | 45 | 19 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Hans Tanner | M | 72 | 15 years | |
Diana Harbort | F | 57 | 7 years | |
Richard W. Bauer | M | - |
Osteotech, Inc.
Osteotech, Inc. Medical SpecialtiesHealth Technology Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ. | 12 years |
Jan Egbert de Vries | M | 80 | - | |
David Hale | M | 75 | 2 years | |
Roberto Camerini | M | 61 | 2 years | |
Maurizio Baldassarini | M | - | 4 years | |
Eimar Cowhey | F | 58 | - | |
Giuseppe Cipriano | M | 67 | - | |
Kenneth Fallon | M | 84 |
Osteotech, Inc.
Osteotech, Inc. Medical SpecialtiesHealth Technology Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ. | 15 years |
Øyvind Bjordal | M | 58 | - | |
Martina Cartwright | M | - | 4 years | |
Stefano Selva | M | 47 | - | |
Sheetal Sahel | F | - | - | |
Louise Dube | M | - | 1 years | |
Roberta Bozzella | F | 50 | 20 years | |
Richard Jones | M | 55 | - | |
John Donatello Manieri | M | - | - | |
Sean MacDonald | M | 47 | 2 years | |
Blake A. Boland | M | 64 | - | |
Friedrich von Bohlen und Halbach | M | 60 | 11 years | |
James L. Russell | M | - |
Osteotech, Inc.
Osteotech, Inc. Medical SpecialtiesHealth Technology Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ. | - |
Susanna Priori | F | 55 |
Giuliani SpA
Giuliani SpA Pharmaceuticals: MajorHealth Technology Giuliani SpA manufactures and distributes health and beauty products. It develops products and has contributed to promoting pharmaceutical awareness among the public, becoming one of Italy's pharmaceutical manufacturers. The company was founded in 1889 by Germano Giuliani and is headquartered in Milan, Italy. | 11 years |
Statistics
Country | Connections | % of total |
---|---|---|
Ireland | 20 | 54.05% |
Italy | 16 | 43.24% |
United States | 3 | 8.11% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Luigi Moro
- Personal Network